Robyn Hunter - 09 Jun 2022 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 21:19:54 UTC
Previous filing
31 Jan 2022
Next filing
12 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +6,250 $0.000000 6,250 09 Jun 2022 Common Stock 6,250 $0.6200 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.